Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

TRUB2 Inhibitors

TRUB2 inhibitors are a class of chemical compounds designed to target and inhibit the activity of TRUB2, a member of the TruB family of pseudouridine synthases. TRUB2 is responsible for catalyzing the isomerization of uridine to pseudouridine in RNA molecules, particularly in transfer RNA (tRNA) and ribosomal RNA (rRNA). Pseudouridine plays a crucial role in stabilizing RNA structures, enhancing base-pairing interactions, and supporting the proper function of the translational machinery. By inhibiting TRUB2, these compounds disrupt the formation of pseudouridine, potentially affecting the stability and functionality of RNA molecules in processes like protein synthesis and RNA processing.

The mechanism of TRUB2 inhibitors typically involves binding to the active site of the enzyme, preventing it from catalyzing the conversion of uridine to pseudouridine. These inhibitors may also alter the enzyme's conformation, rendering it unable to interact with its RNA substrates. Researchers use TRUB2 inhibitors to investigate the role of pseudouridine in RNA structure and function, exploring how changes in RNA modification can influence cellular processes such as translation and RNA stability. By inhibiting TRUB2, scientists can gain insights into the molecular mechanisms of RNA modification and how disruptions in these processes impact cellular homeostasis and gene expression. These inhibitors provide valuable tools for studying the broader significance of RNA modifications in biology, particularly in understanding how pseudouridine contributes to the efficiency and accuracy of the cellular machinery responsible for protein synthesis and gene regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Binds to DNA and prevents RNA synthesis by inhibiting RNA polymerase, indirectly affecting TRUB2 activity by reducing tRNA substrate availability.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

Inhibits RNA polymerase II and, to a lesser extent, RNA polymerase III, potentially decreasing tRNA transcription and indirectly reducing TRUB2 activity.

Cordycepin

73-03-0sc-203902
10 mg
$99.00
5
(1)

Inhibits RNA polymerase by terminating RNA chain elongation and can indirectly affect TRUB2 by reducing the pool of tRNA substrates.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$105.00
$408.00
$1224.00
35
(2)

Inhibits exportin 1 (CRM1), which could result in altered nuclear-cytoplasmic transport of tRNA, indirectly impacting TRUB2 function.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$68.00
$261.00
8
(1)

Inhibits inosine monophosphate dehydrogenase, leading to depleted guanine nucleotide pools and potentially affecting tRNA synthesis and TRUB2's role therein.

Ribavirin

36791-04-5sc-203238
sc-203238A
sc-203238B
10 mg
100 mg
5 g
$62.00
$108.00
$210.00
1
(1)

Interferes with inosine monophosphate dehydrogenase, affecting RNA metabolism and indirectly TRUB2 function due to altered tRNA synthesis.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Blocks N-linked glycosylation and can lead to misfolded proteins that may interrupt cellular homeostasis and indirectly affect TRUB2.

Neomycin sulfate

1405-10-3sc-3573
sc-3573A
1 g
5 g
$26.00
$34.00
20
(5)

An aminoglycoside that binds to RNA, potentially preventing TRUB2 from accessing its tRNA substrate.

Quinacrine, Dihydrochloride

69-05-6sc-204222
sc-204222B
sc-204222A
sc-204222C
sc-204222D
100 mg
1 g
5 g
200 g
300 g
$45.00
$56.00
$85.00
$3193.00
$4726.00
4
(2)

Interferes with RNA function and can bind to nucleic acids, possibly affecting TRUB2's interaction with tRNA.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

Inhibits RNA polymerase II and III, potentially reducing tRNA synthesis and indirectly affecting TRUB2 activity.